MCM
SGMO

McKinley Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

McKinley Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,543
Closed -$24K – 275
2019
Q1 		$24K Hold
2,543
– – ﹤0.01% 266
2018
Q4 		$29K Sell
2,543
-2,868
-53% -$35.6K ﹤0.01% 269
2018
Q3 		$92K Sell
5,411
-435
-7% -$6.61K 0.01% 264
2018
Q2 		$83K Buy
5,846
+2,414
+70% +$40.1K 0.01% 281
2018
Q1 		$65K Sell
3,432
-95,723
-97% -$2.05M ﹤0.01% 290
2017
Q4 		$1.63M Buy
99,155
+66
+0.1% +$982 0.08% 176
2017
Q3 		$1.49M Buy
+99,089
New +$1.1M 0.06% 191

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

McKinley Capital Management's SGMO Position: Q2 2019 in Review

McKinley Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 2,543 shares — an estimated $24K sold.

McKinley Capital Management first reported a position in SGMO in Q3 2017 and held it in 7 quarters. The position peaked at $1.63M in Q4 2017. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • McKinley Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • McKinley Capital Management sold 2,543 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $24K.
  • McKinley Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2017 and held it in 7 quarters.
  • McKinley Capital Management's SANGAMO THERAPEUTICS INC position peaked at $1.63M in Q4 2017.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on McKinley Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.